# EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations

> **NCT06716580** · NA · RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 1000 (estimated)

## Conditions studied

- Lung Cancer
- EGFR Gene Mutation

## Interventions

- **DEVICE:** Circulating Tumor DNA (ctDNA) Assay

## Key facts

- **NCT ID:** NCT06716580
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2027-09-01
- **Final completion:** 2030-09-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-12-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06716580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06716580, "EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06716580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*